TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 2 | 1 | 3 | 4 | -1 | -21 | -17 | -34 | -67 | -23 |
| P | %wins | 67 | 67 | 33 | 0 | 0 | 0 | 28 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/2/17 06:01 | 5/19/17 | MBVX | Mabvax Therapeutics Holdings, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hanson Gregory P | CA | O | CFO,SECR | P.d | 8 | 0.8217 | 0 | 9 | 31 | 38 | D | ||||||||||||||
8/19/16 16:36 | 8/17/16 | MBVX | Mabvax Therapeutics Holdings, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hanson Gregory P | CA | O | CFO,SECR | P.d | 0 | 0.00 | 0 | 3 | 23 | 17 | D | -89 | -59 | 39 | 14 | 18 | 16 | 16 | 7 | 6 | 5 | 1 | -16 | -35 | |
12/17/14 13:52 | 12/16/14 | MBVX | Mabvax Therapeutics Holdings, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hanson Gregory P | CA | O | CFO | P | 8 | 2.50 | 0 | 3 | New | 3 | D | -86 | -77 | -81 | -76 | -57 | -10 | -31 | -24 | -4 | -12 | -37 | -18 | -1 | -68 |
5/26/06 14:41 | 5/26/06 | AVNR | Avanir Pharmaceuticals | CA | Health | Drug | Pharmaceutical Preparations | Hanson Gregory P | CA | O | VP,CAO | P | 11 | 9.67 | 4 | 1 | 27 | 5 | 10 | 5 | -27 | -16 | -67 | -65 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |